BioNTech SE (BNTX)

NASDAQ: BNTX · Real-Time Price · USD

102.58

-1.57 (-1.51%)

At close: May 01, 2025, 3:59 PM

104.93

2.29%

Pre-market: May 02, 2025, 07:25 AM EDT

BioNTech SE Cash Flow Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-677.7M	1.19B	12.95B	15.05B	-145.8M	-179.44M	-47.66M	-85.91M
Depreciation & Amortization	298M	183.4M	123.3M	75.2M	38.74M	33.9M	21.98M	10.53M
Stock-Based Compensation	100.9M	51.4M	108.6M	93.9M	32.1M	30.2M	7.64M	5.91M
Other Working Capital	n/a	n/a	-50.87M	n/a	n/a	n/a	n/a	n/a
Other Non-Cash Items	-734.1M	-1.62B	-4.13B	212.5M	114.47M	262K	-226K	-1.4M
Deferred Income Tax	n/a	n/a	n/a	-3.79B	40.06M	-54K	1.04M	26.27M
Change in Working Capital	1.22B	5.57B	4.52B	-10.73B	-93.1M	-83.44M	-40.96M	-7.96M
Operating Cash Flow	207.7M	5.37B	13.58B	889.7M	-13.47M	-198.54M	-58.18M	-52.56M
Capital Expenditures	-452.3M	-705.5M	-363.3M	-154M	-85.45M	-71.08M	-67.85M	-57.74M
Cash Acquisitions	n/a	-336.9M	589.19K	-20.8M	-60.64M	-6.06M	727.57K	4.88M
Purchase of Investments	-12.37B	-6.98B	-47.8M	-394.7M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	10.74B	1.19B	375.2M	26.5M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-164.6M	-576.59M	10.81K	-23.1M	1.24M	21K	706K	5.19M
Investing Cash Flow	-2.08B	-6.95B	-35.3M	-566.1M	-144.85M	-77.11M	-67.15M	-52.55M
Debt Repayment	-45.9M	-40.1M	-59.1M	-66.7M	141.7M	7.9M	3.45M	-1.64M
Common Stock Repurchased	n/a	-738.5M	-986.4M	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	-475.58M	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	110.5M	160.9M	51.45M	-10K	n/a	n/a
Financial Cash Flow	-45.9M	-778.6M	-1.42B	94.2M	894.73M	383.29M	365.18M	-1.64M
Net Cash Flow	-1.9B	-2.21B	12.18B	482.5M	691.06M	107.65M	239.39M	-131.57M
Free Cash Flow	-244.6M	4.67B	13.21B	735.7M	-98.92M	-269.62M	-126.03M	-110.3M